Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

279
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
279
What is Conservation Biology?01:57

What is Conservation Biology?

24.4K
Conservation biology is a scientific field that focuses on the preservation of biodiversity in order to protect ecosystems while meeting the needs of the human population. Humans require properly functioning ecosystems to maintain our supply of natural resources, including food, medicines, and building materials.
24.4K
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

335
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
335
Biological Effects of Radiation02:59

Biological Effects of Radiation

18.0K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
18.0K
Synthetic Biology02:55

Synthetic Biology

5.6K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.6K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

626
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Evaluation of preoperative nutritional status in visceral surgery Correlational study].

Journal de pharmacie de Belgique·2018
Same journal

[Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].

Journal de pharmacie de Belgique·2018
Same journal

[Medication screening by the community pharmacist in Belgium].

Journal de pharmacie de Belgique·2018
Same journal

[Frequency and nature of drug related problems with corticosteroids in Belgian community pharmacies].

Journal de pharmacie de Belgique·2018
Same journal

[A practical program for outpatient parenteral antimicrobial therapy].

Journal de pharmacie de Belgique·2018
Same journal

[Reliability of OTC advertisement Relevance and quality of cited literature].

Journal de pharmacie de Belgique·2018
See all related articles

Related Experiment Video

Updated: Feb 4, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

[Biosimilars, no generic biologicals!].

B Knuts

    Journal De Pharmacie De Belgique
    |October 4, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Biosimilars offer cost-effective alternatives to biological medicines after patent expiry. Understanding their unique characteristics, regulatory approval, and evolving knowledge on safety is crucial for healthcare professionals and patients.

    More Related Videos

    Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
    06:24

    Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

    Published on: December 15, 2017

    10.7K
    The Use of Chemostats in Microbial Systems Biology
    13:19

    The Use of Chemostats in Microbial Systems Biology

    Published on: October 14, 2013

    31.8K

    Related Experiment Videos

    Last Updated: Feb 4, 2026

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    18.3K
    Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
    06:24

    Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

    Published on: December 15, 2017

    10.7K
    The Use of Chemostats in Microbial Systems Biology
    13:19

    The Use of Chemostats in Microbial Systems Biology

    Published on: October 14, 2013

    31.8K

    Area of Science:

    • Biotechnology
    • Pharmacology
    • Health Economics

    Background:

    • Biological medicines are essential for treating chronic diseases.
    • Biosimilars, or generic biologicals, are emerging post-patent expiry.
    • There is significant interest in biosimilars due to their potential cost savings.

    Purpose of the Study:

    • To inform stakeholders about the features of biosimilars.
    • To highlight the differences between biosimilars and generic drugs.
    • To emphasize the importance of knowledge regarding biosimilars.

    Main Methods:

    • Review of regulatory pathways for biosimilar approval.
    • Analysis of scientific literature on biosimilar characteristics.
    • Discussion of pharmacovigilance and traceability requirements.

    Main Results:

    • Biosimilars are not identical to originator biologics due to complex manufacturing.
    • Regulatory approval requires demonstrated similarity in efficacy, safety, and activity.
    • Knowledge regarding immunogenicity, interchangeability, and substitution is continuously updated.

    Conclusions:

    • Biosimilars represent a significant development in therapeutic options.
    • Traceability is essential for effective pharmacovigilance as more biosimilars enter the market.
    • Pharmacists require adequate training and information to support patients regarding biosimilars.